Lung function and disease activity in sarcoidosis - Disease activity in sarcoidosis

被引:0
|
作者
Bradvik, I
Wollmer, P
Evander, E
Sloth, M
Larusdottir, H
BlomBulow, B
Jonson, B
机构
[1] MALMO UNIV HOSP, DEPT CLIN PHYSIOL, MALMO, SWEDEN
[2] UNIV LUND HOSP, DEPT CLIN PHYSIOL, S-22185 LUND, SWEDEN
[3] UNIV LUND HOSP, DEPT DIAGNOST RADIOL, S-22185 LUND, SWEDEN
来源
关键词
lung function measurements; radionuclide imaging; inflammation; exercise testing; technetium-99m pertechnetate; gallium radioisotopes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In sarcoidosis the lung clearance of inhaled Tc-99m-labelled diethylene triamine pentaacetic acid (DTPA) is often abnormal. Few studies related the lung clearance of Tc-99m-DTPA to the results of other lung function tests and/or disease activity parameters. This study describes the relationship in sarcoidosis between the lung clearance of Tc-99m-DTPA measured over 180 minutes, and a set of function tests comprising lung volumes and lung mechanics as well as arterial blood gases. Disease activity was assessed with serum angiotensin-converting enzyme (SACE) and Ga-67 scintigraphy. Measurements of lung clearance, spirometry and SACE were thus performed in 41 never-smoking patients with radiologic signs of intrathoracic sarcoidosis. In 32 patients a Ga-67 scan was obtained. The clearance of Tc-99m-DTPA was abnormal in 23 patients. Either an abnormally fast mono-exponential clearance or a bi-exponential clearance course was disclosed. In 17 of these patients, dynamic spirometry was normal. The Ga-67 scan was abnormal in 15 patients. There was a significant association between abnormal lung clearance of Tc-99m-DTPA and abnormal pulmonary uptake of Ga-67. This suggests that lung clearance of Tc-99m-DTPA may be used as a means for assessing disease activity in pulmonary sarcoidosis.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 50 条
  • [1] Chitotriosidase as a marker of disease activity in sarcoidosis
    Brunner, Juergen
    Scholl-Buergi, Sabine
    Prelog, Martina
    Zimmerhackl, Lothar-Bernd
    [J]. RHEUMATOLOGY INTERNATIONAL, 2007, 27 (12) : 1185 - 1186
  • [2] Chitotriosidase as a marker of disease activity in sarcoidosis
    Jürgen Brunner
    Sabine Scholl-Bürgi
    Lothar-Bernd Zimmerhackl
    [J]. Rheumatology International, 2007, 27
  • [3] Chitotriosidase as a marker of disease activity in sarcoidosis
    Jürgen Brunner
    Sabine Scholl-Bürgi
    Martina Prelog
    Lothar-Bernd Zimmerhackl
    [J]. Rheumatology International, 2007, 27
  • [4] PULMONARY SARCOIDOSIS - ASSESSMENT OF DISEASE-ACTIVITY BY LUNG LYMPHOCYTE SUBPOPULATIONS
    COSTABEL, U
    BROSS, KJ
    MATTHYS, H
    [J]. KLINISCHE WOCHENSCHRIFT, 1983, 61 (07): : 349 - 356
  • [5] Cardiac sarcoidosis: A challenge to measure disease activity
    Ruth G. M. Keijsers
    Fred J. Verzijlbergen
    Benno J. W. M. Rensing
    Jan C. Grutters
    [J]. Journal of Nuclear Cardiology, 2008, 15 : 595 - 598
  • [6] Cardiac sarcoidosis: A challenge to measure disease activity
    Keijsers, Ruth G. M.
    Verzijlbergen, Fred J.
    Rensing, Benno J. W. M.
    Grutters, Jan C.
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2008, 15 (04) : 595 - 598
  • [7] Lymphopenia as a Marker of Disease Activity and Severity in Sarcoidosis
    Manansala, Michael
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1648 - 1650
  • [8] CA 15.3: A MARKER OF DISEASE ACTIVITY IN SARCOIDOSIS
    Turk, Yasemin
    Shapiro, Clara
    Braunstahl, Gert-Jan
    [J]. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2017, 34 (01) : 100 - 101
  • [9] Interstitial Lung Disease and Sarcoidosis
    Sharp, Michelle
    Mustafa, Ali M.
    Farah, Naima
    Bonham, Catherine A.
    [J]. CLINICS IN CHEST MEDICINE, 2023, 44 (03) : 575 - 584
  • [10] Impact of gender on disease activity, pulmonary function and health status in sarcoidosis patients - King's sarcoidosis questionnaire (KSQ)
    Gvozdenovic, Branislav S.
    Patel, Amit Suresh
    Birring, Surrinder S.
    Vucinic, Violeta
    Vukovic, Mira
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42